Physician profile
Amanda Cooley
NPI 1841723251
$454.93
in general payments reported to CMS, 2019-2025
13 companies · $34.86 in 2025
The $34.86 reported for 2025 was less than what a typical Geriatric Medicine (Internal Medicine) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $16.95 · 2021: $167 · 2022: $136 · 2023: $84.12 · 2024: $16.12 · 2025: $34.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $135.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $136.58 | 2021-2023 | Vraylar |
| Novo Nordisk INC | $131.34 | 2021-2025 | Ozempic |
| Abbott Laboratories | $29.04 | 2023-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Merck Sharp & Dohme LLC | $20.61 | 2021 | |
| Avanir Pharmaceuticals, INC. | $17.06 | 2022 | |
| Lilly USA, LLC | $17.02 | 2025 | Jardiance |
| Biogen, INC. | $16.95 | 2020 | |
| Janssen Pharmaceuticals, INC | $15.76 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.45 | 2022 | |
| Glaxosmithkline, LLC. | $14.98 | 2023 | Bexsero, Rotarix, Pediarix |
| Agile Therapeutics, INC. | $13.68 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $13.55 | 2023 | Rexulti |
| Astrazeneca Pharmaceuticals Lp | $12.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Cooley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.